Equity capital funds concentrated on start-ups in the quickly growing marijuana market are raising tons of capital, and Elevation Financial Investment Management is no exception.

The New york city City-based company is seeking to raise over $100 million for its 2nd marijuana fund, according to individuals knowledgeable about the matter.

Elevation’s 2nd fund is set to be a significant boost over its very first. The company’s very first fund closed at $30 million in 2015 and is released throughout 16 business in the marijuana sector, consisting of BDS Analytics, an information company, and Front Variety Biosciences, a biotech start-up.

Find Out More: The top 12 venture-capital companies making handle the growing marijuana market that’s set to escalate to $75 billion

The fund’s partners consist of John Brecker and Michael Goldberg, who both operated at the $2.7 billion Longacre Fund Management, Roderick Stephen, who established Longacre’s UK group and operated at Castle Financial investment Group, and Jon Trauben, an industrial property veteran who did stints at Barclays and Credit Suisse.

‘They’re not being thought up in garages any longer’

Trauben informed Service Expert in an interview that Elevation’s much bigger Fund II represents a shift in how the marijuana market is developing, with incumbent business “boxing out” brand-new start-ups that increase to challenge them– and requiring capital to sustain that development.

“The set of business that will win the market currently exist,” stated Trauben. “They’re not being thought up in garages any longer.”

While Elevation will not eliminate buying public business, the focus will be on growth-stage start-ups. The dominating concern, then, for Elevation’s 2nd fund will be choosing which business will “pull ahead.”

“We remain in the 2nd half of the start-up community,” stated Trauben. “There’s still space for originalities and brand-new business, however it’s not like it was 2 or 3 years earlier.”

In regards to what parts of the market Elevation is taking a look at the majority of carefully, Trauben stated the company takes a “quite broad view” of marijuana, however he’s especially bullish on customer brand names, and the exit chances those brand names present canny financiers.

He indicated Green Thumb Industries current acquisition of Beboe, a high end cannabis brand name. “I believe 2019 would actually be the year of the brand names for marijuana area,” stated Trauben.

Find Out More: Biotech, CBD beverages, and a hot vape business: Here’s where all the leading cannabis VCs are seeking to compose checks this year

Another location of interest: farming innovation. Trauben stated there’s a variety of start-ups dealing with establishing cannabinoids– the active substances in the marijuana plant– through cellular hosts like yeast and algae.

As huge customer packaged items corporations race to develop drinks and other items including CBD and THC, 2 of the most popular marijuana components, this innovation might possibly end up being “really disruptive,” stated Trauben.

‘The real product in this market today is info’

Unlike some other marijuana funds, Trauben states Elevation will not avoid investing straight in “plant-touching” business, though cannabis is federally unlawful in the United States.

That becomes part of what the majority of cannabis-specific funds state provides an edge over more conventional equity capital and personal equity companies, like Lerer Hippeau and Greycroft, who are gradually getting more comfy buying the area

In Trauben’s view, funds like Elevation that are utilized to handling the intricacies of running in a market that’s growing so quickly while being federally unlawful represent the very best opportunities of “getting it right.”

“The real product in this market today is info,” stated Trauben. “If you’re not seeing that info circulation– the networks and the relationships you have actually constructed– you simply do not have the ideal information.”

Financiers in other, more fully grown sectors, like tech or property, have years of information and historic precedent at their fingertips when examining offers.

“I believe when you move from that environment to this environment, you recognize what’s missing out on and to develop that understanding circulation does not take place overnight,” stated Trauben. “It takes a collective effort.”

Elevation signs up with a variety of other cannabis-specific companies who are raising brand-new funds this year, consisting of Tuatara Capital, Poseidon Possession Management, and 7thirty, to name a few.